anthony rowbottom

It was a pleasure to interview the the wonderful Jane Frost CBE, CEO of the Market Research Society (MRS) about her ED&I journey and the vitally important MRS Inclusion Pledge. There are so many reasons to sign the Inclusion Pledge and no reasons why an organisation in the sector shouldn't. Here's a link to the podcast. https://lnkd.in/dXkKHzhT #marketresearch #marketresearchsociety #mrs #inclusion #inclusionpledge #bethechange Truth Consulting

22

12 Comments

Report published by FirstWord Research, 30 April 2024 Authors Dr Cheryl Barton & Dr Bianca Piachaud-Moustakis at PharmaVision UK Leveraging Real-World Data with AI to Enhance Comparative Effectiveness Research How are AI-enabled tools transforming the use of real-world data (RWD) in Comparative Effectiveness Research (CER)? Advanced analysis of diverse data sources such as electronic health records, patient registries, wearable data, and genomics reports is providing a more nuanced understanding of the patient experience. As payer and regulator demand grows, what are the key CER elements that will feed into approval, pricing and reimbursement decision-making? https://lnkd.in/dSevZ8by

1

'Even small changes can introduce a lot of factors we have to consider". Revisit our #InsightstoActivate webinar to hear experts from Ford, Regeneron, and Ipsos explain how brands can mitigate tomorrow’s risks by planning today. https://lnkd.in/eY7Fwanp 🎞 revisit panel discussion 📚 read our detailed Point of View 🔦 explore our toolkit + Impact Story ❤️ bookmark our series

2

Our Research Partnership #LivingWith syndicated reports bring a unique view of the experiences of patients living with a wide variety of specific chronic diseases. We have just launched our latest report, Living With Systemic Sclerosis (SSc), which includes valuable insights into the unmet needs and burden experienced by patients living with SSc. Plenty in here to help improve knowledge of the SSc patient landscape and patient journey from diagnosis, enabling you to build a picture of resources needed at key points during the patient journey to ensure patient support resources are optimally utilized. Learn more about the report here and get in touch if you want a copy: https://lnkd.in/edYyf82n #MRX #Patient #Insights #Healthcare #Pharma

23

The Placebo Effect can have a bad reputation in some quarters (I know plenty of pharmacists …) but is its reputation deserved? The way we perceive and interpret the world has such a powerful impact on our wellbeing and our actions – the perceived world is the real world. This has such a wideranging impact no matter what industry you work in (government, financial services, telco etc.) or role (e.g. marketing, product, CX). So “Is Optimism the World's Most Powerful Placebo Effect?”. In all likelihood, yes. An optimistic read to start the week with. https://lnkd.in/gv-5UtSS

6

BiTEs or CAR-T for R/R Follicular Lymphoma? Key Insights from EHA2024 Attended a thought-provoking educational session at #EHA2024 in a unique format. After seeing numerous presentations, I think it's best to highlight the key points into a single slide. #ipsos #hematology #follicularlymphoma #immunotherapy #CARTtherapy #bispecificantibodies

18

1 Comment

As we conclude this month's exploration of the dynamic metabolic disease sector, driven by the groundbreaking #GLP1 treatment category in #diabetes and #obesity, take a look at the recent findings by EOS Intelligence. The collection was published in May 2024. Can GLP-1 become the new game changer for NASH? https://lnkd.in/gTBrGam9 GLP-1 Drugs - The disruptive force shaping the pharmaceutical industry https://lnkd.in/gtM7kQzP Acromegaly – Evolving therapeutic priorities https://lnkd.in/gqZhA93a Can Lilly’s once-a-week Insulin prove as a gamechanger in the slowing insulin market? https://lnkd.in/gf5RXfMn Future of cell therapy in type 1 diabetes https://lnkd.in/ggcAi_jv The world of diabetes care is rapidly evolving https://lnkd.in/gJK64zgU Tolerability, pricing of oral semaglutide frequent areas of investor debate https://lnkd.in/gfG3SApt Transformational time in obesity treatment https://lnkd.in/gKap5j-H Eli Lilly’s retatrutide emerge as a game-changer in obesity treatment? https://lnkd.in/gPdns5Jm Metabolic disorders are swiftly becoming a key focus for pharmaceutical companies https://lnkd.in/g9UZm_Bq

11

Join us on Wednesday for this important update

6

2 Comments

An impact for sure, but how much and on which Technologies the most?

2

Despite a decrease in crime in England and Wales, a majority of Britons, 6 out of 10, believe that crime in the UK has actually increased in the past year, according to new polling by Ipsos UK. The survey also revealed that a significant 79% of Britons view crime as a major issue in the country. When it comes to their local areas, people are a bit more hopeful, with 41% considering crime and anti-social behavior a big problem. However, 43% admit to personally worrying about becoming a victim of crime, especially among those aged 18-34 (56%) and ethnic minorities (61%). Interestingly, 62% of individuals aged 55-75 are not concerned about falling victim to crime. In order to further reduce crime, the public believes that having more police on the streets, improved parenting, and longer prison sentences with no early releases are key factors. Despite this, 67% of individuals rarely or never see uniformed police officers patrolling their local areas, even though a similar percentage believes that having more police officers present would help combat crime and anti-social behavior. The approach to reducing crime differs among Conservative and Labour voters. Conservative voters lean towards initiatives like more uniformed police presence, longer prison sentences, better parenting, improved discipline in schools, and even capital punishment for murder. On the other hand, Labour voters focus on preventative measures such as enhanced parenting, increased youth activities, greater investment in mental health services, behavior change programs, and better support for drug and alcohol addiction. Hannah Shrimpton, Head of Crime and Justice research at Ipsos UK, notes that the poll aligns with our election campaign tracker, indicating that crime and anti-social behavior are becoming more prominent concerns as the election draws nearer. #Crime #ASB #CrimeResearch #GE2024

3

1 Comment

Insights St Paul’s and sunshine! Can’t be beat. As someone who mostly attends innovation and consumer research focussed conferences I’m having a great time learning at EPHMRA conference today. An immersion in all the latest Health Care research trends. Really high standard of talks. Lots of new tech. And… Actual practical examples of AI adding value. Can’t wait to introduce Clickscape to the group tomorrow. No matter what the sub genre of research - we can all benefit from a more accurate understanding of real word moments. Blue Yonder Research Jonathan Million CMRS Becky Coates MCIM CMktr Annie Tran Kate Binner Karen Schofield #moments #marketresearch #healthcare

52

3 Comments

Allergy Diagnostics Market 2024-2032: Global Research Report The allergy diagnostics market is witnessing significant growth, driven by the increasing prevalence of allergies and a heightened focus on early detection and efficient treatment. Our recently published market research report offers a comprehensive analysis of this sector, covering both quantitative and qualitative dimensions. We provide insights into the competitive landscape of manufacturers, examine growth patterns across different regions, and shed light on the diverse types of allergy diagnostic tests available and their applications. Additionally, our report explores the wide range of applications for allergy diagnostics in various healthcare settings and provides detailed profiles of leading companies in the industry. Accompanied by market share estimates for 2024, these profiles offer valuable insights for businesses seeking strategic partnerships or investments. Moreover, our market forecasts empower companies with segment-wise growth calculations and projections from 2024 to 2032, enabling them to identify lucrative market niches for strategic expansion and enhanced market penetration. To Know Global Scope and Demand of Allergy Diagnostics Market. Request for Sample PDF: https://lnkd.in/gP9jCuHe Market Segmentation *By Type: Skin Prick Tests, Blood Tests (In Vitro Allergy Tests), Molecular Allergy Tests, Challenge Tests *By Application: Food Allergy Testing, Drug Allergy Testing, Respiratory Allergy Testing, Insect Sting Allergy Testing, Skin Allergy Testing *By Key Players: Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers AG, Danaher Corporation, ALK ABELLO SPA A/S, Phadia AB, Bio-Rad Laboratories, Inc., Meridian Bioscience Inc., Inc., Omega Diagnostics, Stallergenes Greer plc, Lofarma S.p.A., Torrey Pines, AKERS BIOSCIENCES INC #: #allergydiagnostics #allergytesting #allergies #healthcare #medicaldevices #marketresearch #marketanalysis #medicaltechnology #healthcareindustry #life sciences #diagnostics #in vitrodiagnostics #invivodiagnostics #clinicaldiagnostics #immunoassays #allergicreactions #healthcarebusiness #pharmaceuticalindustry #medicaldevicesmarket Top Region for Allergy Diagnostics Market North America: This region holds a significant market share due to high healthcare awareness, disposable income, and a large population with allergies. Europe: Stringent regulations and a well-established healthcare infrastructure contribute to the growth of the allergy diagnostics market in Europe. Asia-Pacific: This region is witnessing a rapid rise in the allergy diagnostics market, fueled by increasing healthcare expenditure, rising disposable income, and growing awareness of allergies.

1

A thought on a Friday about the relationship between your market research and insight agency’s growth, your attitude to risk and willingness to invest. In economic and commercial theory there is a pretty clear positive relationship between how quickly and effectively you can grow your market research agency and your attitude to risk. Why is this? If you don’t have a postive attitude to risk, you will not be prepared to invest in the levers that will grow your business. Essentially this is the risk and reward dynamic. What do I mean by investment? Anything that involves a cost, either a tangible one, or an opportunity cost (we decide to do this over that). Examples of non-cash investment you can make that might be defined as risks: 1) The decision to prioritise activities like budgeting and planning, account management, brand building, innovation in process or proposition, or lead-generation and sales. 2) Setting utilisation expectations that members of your team will not be fully chargeable, so that they spend more time investing in building client relationships is an investment. 3) Even creating content for LinkedIn is an investment! Why are these investments also risks? We cannot guarantee an immediate positive outcome (although if you do them well and consistently they will generate growth in the medium term). And there is an opportunity cost associated with doing these things (for example doing some of these things in a judicious manner, rather than working on commissioned projects from clients all the time and then not, when the work dries up!). My questions to you: * What is your attitude to risk and to opening up your agency’s growth potential? * How are you able or willing to invest? * And what happens if you don’t, especially in a tricky and disrupted trading environment? To give you a hint to that final question, have a look at this highly executed graphic I created! 😉 #mrx #insights #marketresearch #marketingresearch

9

6 Comments